What is the step‑by‑step management of chronic pancreatitis, covering lifestyle modification, pain control, pancreatic enzyme replacement, nutritional support, treatment of endocrine insufficiency, and criteria for endoscopic or surgical intervention?

Management of Chronic Pancreatitis: Step-by-Step Approach

Chronic pancreatitis management requires a structured algorithmic approach prioritizing lifestyle modification first, followed by medical management of pain and pancreatic insufficiency, with surgical intervention preferred over endoscopic therapy for long-term treatment of painful obstructive disease.

Step 1: Lifestyle Modification (Foundation of All Treatment)

• Mandate complete alcohol cessation as alcohol abuse carries an OR of 3.1 (95% CI, 1.87-5.14) for disease progression 1
• Enforce smoking cessation as smoking >35 pack-years increases risk with OR of 4.59 (95% CI, 2.91-7.25) 1
• These interventions must precede all other therapies as they directly address disease progression 2

Step 2: Pain Management (Stepwise Escalation)

Initial Pain Control

• Start with NSAIDs and weak opioids (tramadol) as first-line analgesics 1
• Trial pancreatic enzyme replacement therapy (PERT) as it can control pain symptoms in up to 50% of patients 1
• Add antioxidants (combination of multivitamins, selenium, and methionine) which provide symptom control in up to 50% of patients 1

Pain Management Caveats

• Do NOT routinely perform celiac plexus block for chronic pancreatitis pain 3
• Consider celiac plexus block only on a case-by-case basis in patients with debilitating pain after all other therapeutic measures have failed, and only after discussing unclear outcomes and procedural risks 3
• If celiac plexus block is pursued, use an EUS-guided approach over percutaneous approach 4

Step 3: Pancreatic Enzyme Replacement Therapy (PERT)

• Administer supplemental pancreatic enzymes to all patients with exocrine insufficiency to prevent malnutrition 5
• Exocrine insufficiency occurs in 30-48% of chronic pancreatitis patients 1
• PERT serves dual purposes: preventing malnutrition and potentially controlling pain 1

Step 4: Nutritional Support

• Screen all chronic pancreatitis patients for malnutrition risk as they should be considered at-risk by default 3
• Implement nutritional supplementation accordingly based on screening results 3
• Address osteoporosis and increased fracture risk with preventive measures in all chronic pancreatitis patients 3

Step 5: Treatment of Endocrine Insufficiency

• Monitor for diabetes development which occurs in 38-40% of chronic pancreatitis patients 1
• Manage diabetes according to standard protocols when it develops 6

Step 6: Intervention for Obstructive Disease (Critical Decision Point)

Primary Recommendation: Surgery Over Endoscopy

For patients with painful obstructive chronic pancreatitis, surgical intervention should be considered over endoscopic therapy for long-term treatment 3

Surgical Indications

• Offer surgery for:
  • Intractable pain despite medical management 7
  • Local complications affecting adjacent organs 7
  • Suspicion of malignant or cystic lesions 7
  • Significant calcification and/or mass of the pancreatic head 8

Timing of Surgery

• Favor early surgery (<3 years from symptom onset) over late surgery for superior long-term outcomes 5
• Early intervention achieves optimal long-term pain relief 7

Surgical Procedure Selection

• For enlarged pancreatic head: Use combined drainage and resection procedures (Frey, Beger, or Berne procedure) 7
• For groove pancreatitis: Pancreaticoduodenectomy is the most suitable option 7
• For dilated duct with normal-size pancreatic head: Either extended lateral pancreaticojejunostomy or Frey procedure provides equivalent pain control 7
• Duodenal-preserving strategies are preferred unless cancer is suspected 5

When Endoscopic Therapy Is Appropriate

Endoscopic intervention is a reasonable alternative to surgery ONLY for:

• Suboptimal operative candidates 3
• Patients who strongly favor a less invasive approach after being clearly informed that surgery is primarily favored 3

Step 7: Endoscopic Management (When Surgery Not Pursued)

Pancreatic Duct Stones

• For small stones (≤5mm): Treat with pancreatography and conventional stone extraction 3
• For larger stones: Require extracorporeal shockwave lithotripsy (ESWL) and/or pancreatoscopy with intraductal lithotripsy 3
• Endoscopic extraction is indicated for stone fragments remaining after ESWL 8

Pancreatic Duct Strictures

• Use prolonged stent therapy (6-12 months) for treating symptoms and remodeling main pancreatic duct strictures 3
• Preferred approach: Place and sequentially add multiple plastic stents in parallel (upsizing) 3
• Initial stent management: Use single plastic stent of largest feasible caliber, then replace 2-3 months after insertion 8, 4
• Fully covered self-expanding metal stents may have a role but require additional research 3

Benign Biliary Strictures

• ERCP with stent insertion is the preferred treatment for benign biliary stricture due to chronic pancreatitis 3
• Use fully covered self-expanding metal stents (FCSEMS) over multiple plastic stents whenever feasible, given similar efficacy but significantly reduced need for stent exchange procedures 3, 4

Pancreatic Pseudocysts

• Interventional treatment should be performed for symptomatic or complicated pancreatic pseudocysts 8
• Endoscopic therapy is suggested over surgery for symptomatic pseudocysts 4

Portal-Splenic Vein Thrombosis and Pancreatic Fistula

• Endoscopic drainage is preferred for these complications 8

Hemosuccus Pancreaticus

• Percutaneous endovascular treatment is preferred over endoscopic or surgical approaches 8

Duodenal Stenosis

• Surgical treatment is recommended for duodenal stenosis due to chronic pancreatitis 8

Step 8: Surveillance and Cancer Risk Management

Standard Chronic Pancreatitis

• The risk of pancreatic carcinoma is too low (2% in 10 years) to recommend active screening or prophylactic surgery 7

Hereditary Chronic Pancreatitis

• Patients with hereditary CP have lifetime cancer risk of 40-55% 7
• Prophylactic resection can be considered given this exceptionally high risk 7
• Hereditary pancreatitis is associated with cationic trypsinogen (PRSS1) gene mutations and occurs in approximately 1% of CP cases 1

Critical Pitfalls to Avoid

• Do not use ERCP to treat pain alone in patients with pancreas divisum—there is no role for this 3
• Do not delay surgical evaluation in surgical candidates with painful obstructive CP, as endoscopy should not be first-line 3
• Do not routinely perform celiac plexus blocks as outcomes are unclear and procedural risks are significant 3
• Do not ignore malnutrition screening as all chronic pancreatitis patients are at risk 3
• Do not forget osteoporosis prevention as fracture risk is increased in this population 3